Korro Bio, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 60 FIRST STREET, CAMBRIDGE, MA, 02141
Mailing Address 60 FIRST STREET, CAMBRIDGE, MA, 02141
Phone 617-468-1999
Fiscal Year End 1231
EIN 472324450
Financial Overview
FY2025 FY
$6.39M
Revenue
-$83.58M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 20, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 17, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
Annual Reports
10-K March 12, 2026
- Successful merger with Legacy Korro, creating a focused genetic medicine company with a bolstered pipeline.
- Proprietary ADAR-mediated RNA editing platform offers precise *in vivo* gene correction without altering DNA.
Material Events
8-K Strategy Change March 12, 2026
High Impact
- Successful closing of an oversubscribed $85 million private placement financing.
- Extended financial runway into the second half of 2028, significantly reducing financial risk.
Insider Trading
STRONG BUY 9 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.